Saturday, July 11, 2026

pharma · None - Healthy subjects

SUBSTIPHARM

Substipharm is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include None - Healthy subjects. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to t

Paris, FR HQ
1995 Founded
157 Employees
EMA registrant Type
Company details
Status
Public
HQ
Paris, FR
Founded
1995
Employees
157
Programs
1
Drugs
3
Patents
0
Clinical program

TOP009

Phase 1 · other · None - Healthy subjects

TOP009 for None - Healthy subjects is a Phase 1 program (other) at Substipharm with 1 ClinicalTrials.gov record(s).

← All Substipharm projects Phase 1 other active

Internal code TOP009

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Substipharm
Phase
Phase 1
Modality
other
Indication
None - Healthy subjects
Status
active
Trials
1